Soliris treats chronic hemolysis—the underlying cause of the signs and symptoms of PNH. By blocking complement (one of your body’s defense systems), Soliris reduces hemolysis and therefore improves the symptoms and reduces the major health problems associated with PNH.

Whether you are exploring treatment options or are already on Soliris, you may have questions. Choose the best option to get started. I have recently been diagnosed with PNH. I have had PNH for a while. I am close to someone who has PNH.

Receive a complimentary* Bronze PhRMA Card when you view an interactive, educational presentation about the benefits of Soliris.

View

Whether you've just been diagnosed with PNH or have been living with it for years, education and awareness are the first steps in improving your quality of life.

Want to get up-to-date information about PNH?
Sign up here to receive future educational and support communications. Sign Up

Find helpful resources for living with paroxysmal nocturnal hemoglobinuria (PNH), such as symptom and lab trackers, discussion guides, and more.

* Where allowed by state law



IMPORTANT SAFETY INFORMATION

WARNING: SERIOUS MENINGOCOCCAL INFECTIONS

Soliris increases the risk of meningococcal infections. Meningococcal infection may become rapidly life-threatening or fatal if not recognized and treated early

  • Vaccinate patients with a meningococcal vaccine at least 2 weeks prior to receiving the first dose of Soliris; revaccinate according to current medical guidelines for vaccine use
  • Monitor patients for early signs of meningococcal infections, evaluate immediately if infection is suspected, and treat with antibiotics if necessary

The effect of anticoagulant withdrawal during Soliris treatment has not been studied. Therefore, treatment with Soliris should not alter anticoagulant management.

Soliris is generally well tolerated. The most frequent adverse events observed in clinical studies were headache, a runny nose (nasopharyngitis), back pain, nausea, and tiredness (fatigue).

Please see full prescribing information for SOLIRIS, including boxed WARNING regarding serious meningitis.